Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EOS looks for MelaFind partners:

This article was originally published in Clinica

Executive Summary

Electro-Optical Sciences is seeking commercialisation partners for its hand-held melanoma scanner, which it anticipates launching in mid-2008, subject to US regulatory clearance. Its device, called MelaFind, is a noninvasive, point-of-care instrument that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. Using algorithms, the data are then analysed against a proprietary database of melanomas and benign lesions to provide information to the physician, and produce a recommendation of whether the lesion should be biopsied. Patient accrual in a final blinded pivotal trial of the device is over 20% complete, said the Irvington, New York firm. Four pivotal study sites are active, and additional pivotal trial sites will be activated in the upcoming weeks.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel